Avot Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -72.66%
- Profit Growth -105.50%
- Ebitda -81.52%
- Net Worth -1.48%
- Total Assets 104.20%
About Avot Pharmaceuticals
Avot Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 October 2015 (Nine years and three months 24 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashutosh Kumar and Vivek Singh serve as directors at the Company.
Company Details
-
Location
Solan, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52390HP2015PTC001064
-
Company No.
001064
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Oct 2015
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Avot Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashutosh Kumar
|
Director | 14-Feb-2021 | Current |
|
Vivek Singh
|
Director | 20-Jan-2017 | Current |
Financial Performance of Avot Pharmaceuticals.
Avot Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 72.66% decrease. The company also saw a substantial fall in profitability, with a 105.5% decrease in profit. The company's net worth dipped by a decrease of 1.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avot Pharmaceuticals?
In 2021, Avot Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Y L Pharma Private LimitedAshutosh Kumar and Vivek Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avot Pharmaceuticals?
Unlock and access historical data on people associated with Avot Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avot Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avot Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
